The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Clovis Oncology (Inst); Roche; Tesaro (Inst)
Research Funding - PharmaMar
Travel, Accommodations, Expenses - MSD; Roche
Impact of adding nintedanib to neoadjuvant chemotherapy (NACT) for advanced epithelial ovarian cancer (EOC) patients: The CHIVA double-blind randomized phase II GINECO study.
 
Gwenael Ferron
No Relationships to Disclose
 
Gaetan De Rauglaudre
Travel, Accommodations, Expenses - Pfizer
 
Annick Chevalier
No Relationships to Disclose
 
Pierre Combe
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Chugai Pharma
 
Florence Joly
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD Oncology; Pfizer; Roche; Sanofi; Tesaro
Research Funding - Astellas Pharma; Janssen
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen; Roche; tesaro
 
Alain Lortholary
No Relationships to Disclose
 
Nadia Raban
Research Funding - Arcagy-Gineco (Inst); Gercor (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Salima Hamizi
No Relationships to Disclose
 
Emmanuelle Malaurie
No Relationships to Disclose
 
Marie-Christine Kaminsky
No Relationships to Disclose
 
Patricia Pautier
No Relationships to Disclose
 
Jérome Meunier
No Relationships to Disclose
 
Jérôme Alexandre
Honoraria - AstraZeneca; Ipsen; Novartis; Roche/Genentech; Sanofi/Aventis
Consulting or Advisory Role - AstraZeneca; Ipsen; Novartis; Roche; Sanofi
Travel, Accommodations, Expenses - Janssen; Novartis
 
Dominique Berton-Rigaud
No Relationships to Disclose
 
Anne Floquet
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche; Tesaro
 
Laurence Venat-Bouvet
No Relationships to Disclose
 
Laure Favier
No Relationships to Disclose
 
Nadine Dohollou
Research Funding - Lilly (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Roche (Inst)
 
Coraline Dubot
No Relationships to Disclose
 
Isabelle Laure Ray-Coquard
Honoraria - AstraZeneca; Clovis Oncology; MSD Oncology; PharmaMar; Roche; Tesaro
Consulting or Advisory Role - Abbvie; Amgen; Genmab; Pfizer
Travel, Accommodations, Expenses - Roche